These terms and conditions outline the appropriate and responsible use of the contrast agents, namely Buscopan, Secretin, Mannitol, and Adenosine, as described on the website mrimaster.com. By using these contrast agents, you agree to adhere to the following terms and conditions. It is essential to refer to the provided links for specific dosages, indications, contraindications, and other relevant information before using these contrast agents.

General Information: The information provided on MRIMaster.com is intended for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before using any medication.

Medical Professional Oversight: The administration of Substances during MRI examinations should be carried out under the supervision of qualified medical professionals. The responsibility for determining the appropriateness of using these Substances for an individual patient lies with the medical practitioner or healthcare provider.

1. Adenosine:

• Dosage and Indications: Refer to the dosage, indications, and administration guidelines provided at the following sources:
  • British National Formulary (BNF) – Adenosine
  • FDA Adenosine Label Information
• Contraindications: Adenosine should not be used in patients with known hypersensitivity to adenosine or any of its components. Refer to the provided sources for detailed contraindications.

2. Buscopan:

• Dosage and Indications: Please refer to the recommended dosage, indications, and administration details as provided at the following links:
  • DailyMed – Buscopan FDA Label
  • Medsafe – Buscopan Data Sheet
• Contraindications: Buscopan is contraindicated in patients with a known history of hypersensitivity to hyoscine butylbromide or any of its components. Refer to the provided links for comprehensive contraindications.

3. Mannitol:

• Dosage and Indications: For accurate dosage recommendations and indications, please review the following sources:
  • FDA Mannitol Label Information (2020)
  • FDA Mannitol Label Information (2020) – Alternate Source
  • BNF – Mannitol
• Contraindications: Mannitol is contraindicated in patients with anuria, severe dehydration, and severe pulmonary congestion, among other conditions. Please refer to the provided links for comprehensive contraindications.

4. Secretin:

• Dosage and Indications: For accurate dosage recommendations and indications, please refer to the following sources:
  • FDA Secretin Label Information (2016)
  • Drugs.com – Secretin Dosage
• Contraindications: Secretin should not be administered to patients with a history of hypersensitivity to synthetic human secretin. Please review the provided links for detailed contraindications.

Professional Responsibility:

Healthcare professionals and practitioners are solely responsible for determining the appropriateness of using these Medications for specific patients, based on their medical condition and other relevant factors.

Website References:

The provided website references are for informational purposes only. Users are responsible for ensuring that they have the most up-to-date and accurate information from reliable sources.

Liability Waiver:

The operators of mrimaster.com and its affiliates shall not be held liable for any adverse effects, consequences, or liabilities arising from the use of these Medications in MRI examinations.

Disclaimer: The information provided in these terms and conditions is based on the references mentioned and should not replace professional medical advice. Always consult a qualified healthcare provider before using any contrast agents or medications. The administrators of mrimaster.com are not liable for any misuse, misinterpretation, or adverse effects resulting from the use of these drugs.